Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene

Hypertension Research

Volumn 27, Issue 2, 2004, Pages 119-128

  Ikeda, Yukihiro ^a   Fukuda, Noboru ^a   Wada, Mika ^a   Matsumoto, Taro ^a   Satomi, Aya ^a   Yokoyama, Shin Ichiro ^a   Saito, Satoshi ^a   Matsumoto, Koichi ^a   Kanmatsuse, Katsuo ^a   Mugishima, Hideo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cord blood; Gene and cell therapy; Regenerative medicine; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN RECEPTOR; CADHERIN; CD31 ANTIGEN; CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL BASED GENE THERAPY; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL SEPARATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; ISCHEMIA; LEG BLOOD FLOW; LEG ISCHEMIA; MONONUCLEAR CELL; NONHUMAN; PARAINFLUENZA VIRUS 1; PROTEIN EXPRESSION; RAT; RAT STRAIN; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIUM; VIRUS ENVELOPE;

ANIMALS; ANTIGENS, CD31; BIOLOGICAL MARKERS; CAPILLARIES; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; FETAL BLOOD; GENE EXPRESSION; GENE THERAPY; HINDLIMB; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; REGIONAL BLOOD FLOW; RNA, MESSENGER; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 12144288784     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.119     Document Type: Article

References (25)

1. Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999; 103: 1231-1236.
2. Risau W: Differentiation of endothelium. FASEB J 1995; 9: 926-933.
3. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
4. Asahara T, Takahashi T, Masuda H, et al: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
5. Asahara T, Masuda H, Takahashi T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
6. Tateishi-Yuyama E, Matsubara H, Murohara T, et al: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
7. Murohara T, Ikeda H, Duan J, et al: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
8. Iwaguro H, Yamaguchi J, Kalka C, et al: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-738.
9. Mesri EA, Federoff HJ, Brownlee M: Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circ Res 1995; 76: 161-167.
10. Mocharla H, Mocharla R, Hocks ME: Coupled reverse transcription-polymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping. Gene 1990; 93: 271-275.
11. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
12. Mayani H, Lansdorp PM: Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994; 83: 2410-2417.
13. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
14. Flamme I, Risau W: Induction of vasculogenesis and hematopoiesis in vitro. Development 1992; 116: 435-439.
15. Weiss MJ, Orkin SH: In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest 1996; 97: 591-595.
16. Badorff C, Brandes RP, Popp R, et al: Transdifferentiation of blood-derived human adult endothilial progenitor cells into functionally active cardiomyocytes. Circulation 2003; 107: 1024-1032.
17. Young PP, Hofling AA, Sands MS: VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci USA 2002; 99: 11951-11956.
18. Keyt BA, Nguyen HV, Berleau LT, et al: Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996; 271: 5638-5646.
19. Guo D, Jia Q, Song HY, Warren RS, Donner DB: Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with, endothelial cell proliferation. J Biol Chem 1995; 270: 6729-6733.
20. Sata M, Hirata Y, Nagai R: Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Hypertens Res 2002; 25: 577-582.
21. Iwaguro H, Yamaguchi J, Kalka C, et al: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration, Circulation 2002; 105: 732-738.
22. Tsuboniwa N, Morishita R, Hirano T, et al: Safety evaluation of hemagglutinating virus of Japan - artificial viral envelope liposomes in nonhuman primates. Hum Gene Ther 2001; 12: 469-487.
23. Orlic D: Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol 2002; 76: 144-145.
24. Terada N, Hamazaki T, Oka M, et al: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 1542-545.
25. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.